Six game-changing technologies targeted at disease areas ranging from treatment of autoimmunity, to cancer, glaucoma to receive funding and Bayer mentoring.
Generating Superior ‘Killers’ for Adoptive Cell Therapy in Cancer, Lydia Lynch, PhD, Brigham and Women’s Hospital
Novel Strategies to Enhance Tfr Treatment of Autoimmunity, Peter Sage, PhD, Brigham and Women’s Hospital
Long-Lasting mRNA Therapy for Genetic Disorders, Jinjun Shi, PhD, Brigham and Women’s Hospital
AAV-Based Gene Replacement Therapy Improves Targeting and Clinical Outcomes in a Childhood CNS Disorder, Yulia Grishchuk, PhD, Massachusetts General Hospital
Towards a Permanent Genetic Cure for Spinal Muscular Atrophy, Benjamin Kleinstiver, PhD, Massachusetts General Hospital
Differentiation of Retinal Neurons for Cell Replacement in Glaucoma, Petr Baranov, MD, PhD, Massachusetts Eye and Ear
Most Recent Posts:
Announcing the Brigham Ignite Ignitable Ideas Series
Brigham Ignite is pleased to announce the Ignitable Ideas Series, a virtual educational series for Mass General…
Novel blood test combined with mammography finds cancers sooner, informing treatments and preventing overdiagnoses
Experienced innovator’s technology reduces false-positive results from imaging With plenty of innovations under his belt, David…
Ten Projects Advance at 4th Annual MESH Innovation Teams’ ‘Problem Day’
Top Finalists to Enter Yearlong Program Guiding Their Innovations Aimed at Enhancing Patient Care It’s surely…
